CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-01 | Parsons James T. Director | Grant or award | +8,102 | $4.59 | $37K | 14,202 |
| 2020-06-01 | Parsons James T. Director | Grant or award · Stock Option (right to buy) | +13,306 | 13,306 | ||
| 2020-06-01 | Pilnik Richard D. Director | Grant or award | +10,168 | $4.59 | $47K | 60,846 |
| 2020-06-01 | Pilnik Richard D. Director | Grant or award · Stock Option (right to buy) | +19,220 | 19,220 | ||
| 2019-11-01 | Gilman Sydney A. VP, Regulatory Affairs | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 | ||
| 2019-08-19 | Kellen Scott CFO and Secretary | Purchase | +3,000 | $2.43 | $7K | 10,290 |
| 2019-08-16 | Pilnik Richard D. Director | Purchase | +7,840 | $2.56 | $20K | 50,678 |
| 2019-08-16 | ALCORN HARRY W JR Chief Medical Officer | Purchase | +7,260 | $2.67 | $19K | 8,260 |
| 2019-08-16 | Pauls Dietrich John President and CEO | Purchase | +1,000 | $2.68 | $3K | 30,804 |
| 2019-06-24 | Xiao Zhenyu Director | Grant or award · Stock Option (right to buy) | +12,950 | 12,950 | ||
| 2019-06-24 | Verdoorn Todd A. Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +71,025 | 71,025 | ||
| 2019-06-24 | Pilnik Richard D. Director | Grant or award · Stock Option (right to buy) | +18,700 | 18,700 | ||
| 2019-06-24 | Pauls Dietrich John President and CEO | Grant or award · Stock Option (right to buy) | +264,000 | 264,000 | ||
| 2019-06-24 | Parsons James T. Director | Grant or award · Stock Option (right to buy) | +12,950 | 12,950 | ||
| 2019-06-24 | Kellen Scott CFO and Secretary | Grant or award · Stock Option (right to buy) | +99,750 | 99,750 | ||
| 2019-06-24 | Giuffre Randall Michael Director | Grant or award · Stock Option (right to buy) | +12,950 | 12,950 | ||
| 2019-06-24 | ALCORN HARRY W JR Chief Medical Officer | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2019-05-31 | Pilnik Richard D. Director | Purchase | +19,000 | $2.80 | $53K | 42,838 |
| 2019-05-24 | Kellen Scott CFO and Secretary | Purchase | +4,000 | $2.94 | $12K | 7,290 |
| 2019-03-28 | ALCORN HARRY W JR Chief Medical Officer | Gift | −150 | 1,000 |
Page 9 of 10 · 189 trades